Hormone replacement therapy studies have shown an increase and decrease in breast cancer resulting in 1259 cases of breast cancer from estrogen alone, and 346 cases from Estradiol.
Unopposed estrogen therapy promotes endometrial thickening and can increase the risk of cancer, while progestogen reduces this risk. Estrogen alone 1259 Estradiol 346 
